These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38938756)

  • 1. Unravelling benzazepines and aminopyrimidine as multi-target therapeutic repurposing drugs for EGFR V774M mutation in neuroglioma patients.
    Singh J; Khanduja KL; Avti PK
    Bioimpacts; 2024; 14(3):28876. PubMed ID: 38938756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual functionality of pyrimidine and flavone in targeting genomic variants of EGFR and ER receptors to influence the differential survival rates in breast cancer patients.
    Avti PK; Singh J; Dahiya D; Khanduja KL
    Integr Biol (Camb); 2023 Apr; 15():. PubMed ID: 38084900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of M
    Nath V; Rohini A; Kumar V
    Biocatal Agric Biotechnol; 2021 Oct; 37():102178. PubMed ID: 34611467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring EGFR inhibitors with the aid of virtual screening, docking, and dynamics simulation studies.
    Rehman ZU; Najmi A
    J Biomol Struct Dyn; 2023 Sep; ():1-21. PubMed ID: 37707987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods.
    Ebrahimi M; Karami L; Alijanianzadeh M
    Comput Biol Med; 2022 Aug; 147():105709. PubMed ID: 35728285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing FDA-approved drugs as NLRP3 inhibitors against inflammatory diseases: machine learning and molecular simulation approaches.
    Agarwal V; Haldhar R; Hirad AH; Ahmed B; Han SB; Gupta A; Raj V; Lee S
    J Biomol Struct Dyn; 2024 Feb; ():1-13. PubMed ID: 38400742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational identification of new TKI as potential noncovalent reversible EGFR
    Abdelmalek D; Smaoui F; Frikha F; Ben Marzoug R; Msalbi D; Souissi A; Aifa MS
    J Biomol Struct Dyn; 2024 Jun; 42(9):4870-4887. PubMed ID: 37349947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of FDA-approved drugs with triple targeting mode of action for the treatment of monkeypox: a high throughput virtual screening study.
    Srivastava V; Naik B; Godara P; Das D; Mattaparthi VSK; Prusty D
    Mol Divers; 2024 Jun; 28(3):1093-1107. PubMed ID: 37079243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing of approved drugs for targeting CDK4/6 and aromatase protein using molecular docking and molecular dynamics studies.
    Yousif FA; Alzain AA; Alraih AM; Ibraheem W
    PLoS One; 2023; 18(9):e0291256. PubMed ID: 37682937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(24):1-48. PubMed ID: 23074402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Articulating target-mining techniques to disinter Alzheimer's specific targets for drug repurposing.
    G N S HS; Marise VLP; Rajalekshmi SG; Burri RR; Krishna Murthy TP
    Comput Methods Programs Biomed; 2022 Jul; 222():106931. PubMed ID: 35724476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing of existing FDA approved drugs for Neprilysin inhibition: An
    Sankhe R; Rathi E; Manandhar S; Kumar A; Pai SRK; Kini SG; Kishore A
    J Mol Struct; 2021 Jan; 1224():129073. PubMed ID: 32834116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular docking and dynamics approach to
    Halder D; Das S; Joseph A; Jeyaprakash RS
    J Biomol Struct Dyn; 2023 May; 41(8):3462-3475. PubMed ID: 35285757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potential edible spices as EGFR and EGFR mutant T790M/L858R inhibitors by structure-based virtual screening and molecular dynamics.
    Ahmad Ansari I; Debnath B; Kar S; Patel HM; Debnath S; Zaki MEA; Pal P
    J Biomol Struct Dyn; 2024 Mar; 42(5):2464-2481. PubMed ID: 37349948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies.
    Bilal MS; Ejaz SA; Zargar S; Akhtar N; Wani TA; Riaz N; Aborode AT; Siddique F; Altwaijry N; Alkahtani HM; Umar HI
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clustering based drug-drug interaction networks for possible repositioning of drugs against EGFR mutations: Clustering based DDI networks for EGFR mutations.
    Munir A; Elahi S; Masood N
    Comput Biol Chem; 2018 Aug; 75():24-31. PubMed ID: 29730365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study.
    Baby K; Maity S; Mehta CH; Suresh A; Nayak UY; Nayak Y
    Arch Med Res; 2021 Jan; 52(1):38-47. PubMed ID: 32962867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays.
    Gupta Y; Maciorowski D; Zak SE; Jones KA; Kathayat RS; Azizi SA; Mathur R; Pearce CM; Ilc DJ; Husein H; Herbert AS; Bharti A; Rathi B; Durvasula R; Becker DP; Dickinson BC; Dye JM; Kempaiah P
    Methods; 2021 Nov; 195():57-71. PubMed ID: 33453392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of phytochemicals from
    Yasmeen N; Ahmad Chaudhary A; K Niraj RR; Lakhawat SS; Sharma PK; Kumar V
    J Biomol Struct Dyn; 2023 Dec; ():1-43. PubMed ID: 38141177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug repurposing against the RNA-dependent RNA polymerase domain of dengue serotype 3 by virtual screening and molecular dynamics simulations.
    Gangopadhyay A; Saha A
    J Biomol Struct Dyn; 2023 Jul; 41(11):5152-5165. PubMed ID: 35642087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.